U.S. flag

An official website of the United States government

Program Releases

The Centers for Medicare & Medicaid Services (CMS) issues program releases to states and drug manufacturers participating in the Medicaid Drug Rebate Program. To find prior releases by topic, please use the "Keyword Search" function below.

To further refine your search, we have also posted a Division of Pharmacy Releases Index, which is a compilation of all the State and Manufacturer Releases topics from 1991 to Present. Please download a copy for your reference.

If you have any questions regarding the states and/or drug manufacturer releases, please email MDROperations@cms.hhs.gov.

Disclaimer: Please note that the information provided on this web page does not bind or obligate the Centers for Medicare and Medicaid Services (CMS).  The statements included on this web page are intended to provide information on Medicaid Drug Rebate Program Releases and do not in any way revise or modify the requirements set forth in Section 1927 of the Act, the national drug rebate agreement (NDRA), or regulations.

Page Last Updated on November 13, 2023

Showing 21 to 30 of 119 results

Manufacturer Release 099

Date:
Type: Manufacturer Release
Keywords: Value Based Purchasing, VBP, VBP Arrangements, Medicaid Best Price, Best Price, VBP and Supplemental Rebates, Supplemental Rebates and Managed Care

Manufacturer Release 098

Date:
Type: Manufacturer Release
Keywords: Narrow Exception Guidance, Drug Category, Drug category guidance, Drug category narrow exception

Manufacturer Release 097

Date:
Type: Manufacturer Release
Keywords: Generic Inflation Penalty, Bipartisan Budget Act of 2015, Section 602 of BB 2015, Noninnovator Drugs Penalty, Noninnovator Drugs URA

Manufacturer Release 096

Date:
Type: Manufacturer Release
Keywords: Enforcement of 5i AMP Provisions, Final rule with comment transition period, Final rule with comment enforcement

Manufacturer Release 095

Date:
Type: Manufacturer Release
Keywords: Claims Level Data, Dispute Resolution Prevention, DRP, Civil Monetary Penalty, CMP, OIG, Reporting Requirements, Timely Reporting, product data, Termination Date, Reactivation Date

Manufacturer Release 094

Date:
Type: Manufacturer Release
Keywords: Quarterly Rebate Payments and Available Resources

Manufacturer Release 093

Date:
Type: Manufacturer Release
Keywords: Orphan Drugs

Manufacturer Release 092

Date:
Type: Manufacturer Release
Keywords: Biosimilars, biologic products, BLA, Preferred Drug Lists, Biosimilars and Preferred Drug Lists, MCO utilization data, MCO utilization records, zero and amount reimbursed, BPD, BPD and zero reimbursement amount, postmark dates

Manufacturer Release 091

Date:
Type: Manufacturer Release
Keywords: Timely Reporting of AMP & BP Data, Correctly Reporting of Drug Categories, Terminated Manufacturers from MDR, Terminated Products from MDR, Product Termination for Late Reporting, 12 Quarter Rule for Revisions of AMP & BP, Inquires Reported to Resource Box for Branded Prescription Drugs

Manufacturer Release 090

Date:
Type: Manufacturer Release
Keywords: Baseline Data, Buying a Drug, Sale of Authorized Generics, Branded Prescription Drug Fees
entries